Synthesis and structure-activity relationship of histone deacetylase (HDAC) inhibitors with triazole-linked cap group.

Histone deacetylase (HDAC) inhibition is a recent, clinically validated therapeutic strategy for cancer treatment. Small molecule HDAC inhibitors identified so far fall in to three distinct structural motifs: the zinc-binding group (ZBG), a hydrophobic linker, and a recognition cap group. Here we report the suitability of a 1,2,3-triazole ring as a surface recognition cap group-linking moiety in suberoylanilide hydroxamic acid-like (SAHA-like) HDAC inhibitors. Using "click" chemistry (Huisgen cycloaddition reaction), several triazole-linked SAHA-like hydroxamates were synthesized. Structure-activity relationship revealed that the position of the triazole moiety as well as the identity of the cap group markedly affected the in vitro HDAC inhibition and cell growth inhibitory activities of this class of compounds.

[1]  C. Maroun,et al.  Histone deacetylase inhibitors: latest developments, trends and prospects. , 2005, Current medicinal chemistry. Anti-cancer agents.

[2]  E. V. D. Eycken,et al.  Photoinduced Wolff Rearrangement of α-Diazo-β-Ketophosphonates : A Novel Entry into Substituted Phosphonoacetates , 1984 .

[3]  P. Crooy,et al.  2-Amino-alcohols from α-amino-acids: a single-step mild procedure , 1974 .

[4]  H. Kolb,et al.  The growing impact of click chemistry on drug discovery. , 2003, Drug discovery today.

[5]  H. Heine,et al.  On Cyclic Intermediates in Substitution Reactions. III. The Alkaline Hydrolysis of ε-Bromocaproic and ζ-Bromoenanthic Acids , 1953 .

[6]  Daniel Delorme,et al.  Structurally simple trichostatin A-like straight chain hydroxamates as potent histone deacetylase inhibitors. , 2002, Journal of medicinal chemistry.

[7]  Jessica E. Bolden,et al.  Anticancer activities of histone deacetylase inhibitors , 2006, Nature Reviews Drug Discovery.

[8]  Takayoshi Suzuki,et al.  Novel inhibitors of human histone deacetylases: design, synthesis, enzyme inhibition, and cancer cell growth inhibition of SAHA-based non-hydroxamates. , 2005, Journal of medicinal chemistry.

[9]  L. d’Haenens,et al.  An Efficient Preparation and the Intramolecular Cyclopropanation of a-Diazo-3-Ketophosphonates and a-Diazophosphonoacetates , 1984 .

[10]  S. Thayumanavan,et al.  Supramolecular assemblies from amphiphilic homopolymers: Testing the scope. , 2006, Journal of the American Chemical Society.

[11]  E. Quesada,et al.  One-pot conversion of activated alcohols into terminal alkynes using manganese dioxide in combination with the Bestmann–Ohira reagent , 2005 .

[12]  P. Marks,et al.  Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors , 1999, Nature.

[13]  R. De Francesco,et al.  Crystal structure of a eukaryotic zinc-dependent histone deacetylase, human HDAC8, complexed with a hydroxamic acid inhibitor. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[14]  James M. Morrell,et al.  Structure-activity relationships of aryloxyalkanoic acid hydroxyamides as potent inhibitors of histone deacetylase. , 2007, Bioorganic & medicinal chemistry letters.

[15]  A. Oyelere,et al.  Direct diazo-transfer reaction on beta-lactam: synthesis and preliminary biological activities of 6-triazolylpenicillanic acids. , 2007, Bioorganic & medicinal chemistry.

[16]  S. Schreiber,et al.  Structural biasing elements for in-cell histone deacetylase paralog selectivity. , 2003, Journal of the American Chemical Society.

[17]  R. Breslow,et al.  Development of Cytodifferentiating Agents for Cancer Chemotherapy , 2000 .

[18]  K. Kelly,et al.  Fullerene-terminated alkanethiolate SAMs on gold generated from unsymmetrical disulfides , 1999 .

[19]  Stuart L Schreiber,et al.  Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[20]  R. Ian Freshney,et al.  Culture of Animal Cells: A Manual of Basic Technique and Specialized Applications , 2010 .

[21]  Morten Meldal,et al.  Peptidotriazoles on solid phase: [1,2,3]-triazoles by regiospecific copper(i)-catalyzed 1,3-dipolar cycloadditions of terminal alkynes to azides. , 2002, The Journal of organic chemistry.

[22]  Arun K. Ghosh,et al.  Asymmetric Total Synthesis of the Gastroprotective Microbial Agent AI-77-B. , 2003, European journal of organic chemistry.

[23]  Luke G Green,et al.  A stepwise huisgen cycloaddition process: copper(I)-catalyzed regioselective "ligation" of azides and terminal alkynes. , 2002, Angewandte Chemie.

[24]  H. Hiemstra,et al.  CuI‐Catalyzed Alkyne–Azide “Click” Cycloadditions from a Mechanistic and Synthetic Perspective , 2005 .

[25]  C. Chen,et al.  Structure-based optimization of phenylbutyrate-derived histone deacetylase inhibitors. , 2005, Journal of medicinal chemistry.

[26]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[27]  O. Wiest,et al.  On the function of the 14 A long internal cavity of histone deacetylase-like protein: implications for the design of histone deacetylase inhibitors. , 2004, Journal of medicinal chemistry.

[28]  S. Schreiber,et al.  Nuclear histone acetylases and deacetylases and transcriptional regulation: HATs off to HDACs. , 1997, Current opinion in chemical biology.

[29]  C. Monneret,et al.  Histone deacetylase inhibitors. , 2005, European journal of medicinal chemistry.

[30]  N. Devaraj,et al.  "Clicking" functionality onto electrode surfaces. , 2004, Langmuir : the ACS journal of surfaces and colloids.